Mesenchymal Stem Cells

August 27, 2024

Assessing the Safety of Intrathecal Mesenchymal Regenerative Medicine for Neurological Disorders: Insights from a Comprehensive Systematic Review and Meta-Analysis

Mesenchymal Stem Cells, Neurodegenerative Diseases, Stem Cell Research

Intrathecal cell delivery has emerged as a promising approach for improving the quality of life for patients with neurological conditions, thanks to previous studies showing its safety and potential benefits. As part of this review, Mesa Bedoya et al. summarize the findings of a systematic review and meta-analysis aimed at evaluating the safety of intrathecally…

August 15, 2024

Exploring the Efficacy and Safety of Mesenchymal Regenerative Medicine for Liver Cirrhosis

Mesenchymal Stem Cells, Stem Cell Research

Liver cirrhosis (LC) is a severe global health problem, contributing to an estimated two million deaths annually. LC results from chronic liver diseases such as hepatitis B and C, alcohol consumption, non-alcoholic fatty liver disease, and autoimmune liver disease. When these diseases progress unchecked, they lead to liver cirrhosis, characterized by inflammation and fibrosis. Most…

August 3, 2024

Phase II Trial Shows Promise of Repeated Stem Cell Injections for ALS Treatment

ALS, Mesenchymal Stem Cells, Stem Cell Research

Amyotrophic Lateral Sclerosis (ALS) is a degenerative disease that affects motor neurons in the brain and spinal cord, leading to muscle paralysis and death, typically within 3-5 years of onset. Despite two FDA-approved therapies, Riluzole, and Edravarone, which offer limited benefits, there remains no cure for ALS. Considering this, researchers have turned to Mesenchymal stem…

April 29, 2024

Renal Hypertension Signs, Symptoms, and Treatments

Cardiovascular Disease, Health Awareness, Heart Failure, Kidney Disease, Mesenchymal Stem Cells, Regenerative Medicine

You might think of kidney health problems as separate issues from your blood pressure. However, renal hypertension, a form of high blood pressure, can be just as serious as cardiovascular health conditions. It’s important to understand the link between kidney function and blood pressure. Once your kidneys become compromised, the damage isn’t reversible. Know the…

April 4, 2024

Utilizing Mesenchymal Stem Cells as an Innovative Therapeutic Strategy for Diabetes and Pancreatic Disorders

Diabetes, Mesenchymal Stem Cells, Regenerative Medicine, Stem Cell Research

According to the World Health Organization, an estimated 422 million people worldwide have diabetes. Numerous studies have demonstrated that people with diabetes are at an increased risk of developing both acute and chronic pancreatitis, which increases the risk of developing pancreatic cancer. Considering the lack of effective therapeutic options for pancreatitis and the limited treatment…

April 1, 2024

Pain Management for Fibromyalgia

Age Management, Mesenchymal Stem Cells, Regenerative Medicine, Stem Cell Research, Studies

According to the Centers for Disease Control and Prevention, four million adults in the United States have fibromyalgia. It’s an often-misunderstood condition that leads to systemic joint and muscle pain, along with fatigue, making daily life very difficult. To deal with the pain the condition causes, it’s important to understand why it occurs. Learn more about…

March 28, 2024

Reviewing The Effectiveness of Stem Cell Therapies in Managing Neuropathic Pain

Mesenchymal Stem Cells, Neuropathy, Stem Cell Research

The International Association for the Study of Pain defines neuropathic pain as “pain arising as a direct consequence of a lesion or disease affecting the somatosensory system”. While general neuropathy is diverse by nature, neuropathic lesions generally fall into four categories: focal or multifocal lesions of the peripheral system, general lesions of the peripheral nervous…

March 21, 2024

Regenerative Medicine Options for Neuropathy Pain Management

Mesenchymal Stem Cells, Neuropathy, Stem Cell Research

Neuropathic pain is pain caused as part of a dysfunction in the nervous system, including the peripheral nerves, brain, and spinal cord. Often characterized by spontaneous pain occurring for no specific reason, neuropathic pain can range from mild to severe and is currently estimated to affect 150 million people in the United States. The risk…

March 14, 2024

Mesenchymal Stem Cells for Managing Spinal Cord Injuries

Mesenchymal Stem Cells, Spinal Cord Injury, Stem Cell Research

Nerve damage resulting from stem cell therapy for spinal cord injury (SCI) often leads to temporary or permanent loss of function and contributes to poor quality of life. Most common among males below 30 years of age, SCI recovery has been limited specifically as a result of the low growth capacity of neurons and a…

March 7, 2024

Utilizing Mesenchymal Stem Cells for Spinal Cord Injury Therapy

Mesenchymal Stem Cells, Spinal Cord Injury, Stem Cell Research

Spinal cord injuries (SCI) are the most serious complication associated with spinal injuries and often result in permanent damage to the nervous system. With nearly 300,000 people in the United States living with SCI, the inability to treat these injuries has a significant impact on physical, mental, and financial health. Additionally, while 94% of those…

Do you have questions?

We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!

800-531-0831